| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500595 | Farmacia Hospitalaria | 2007 | 4 Pages |
Abstract
Rituximab is a new perspective for the treatment of refractory autoimmune cytopenias, and has a good safety profile.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
E. MartÃnez Velasco, J.J. Gómez Castillo, M.J. Fernández MegÃa, B. González Joga, D. Barreda Hernández, M.I. Gómez Roncero,